Project Grant HT94252410678
Award Date 9/30/24
Completion Date 9/29/26
Dollars Obligated $653K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Winston-Salem, NC 27157, USA
Similar Awards
- This $299,999 Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports research conducted by Wake Forest University Health Sciences (WFUHS) to develop microparticle delivery of chemokine muteins for guiding chemokine receptor engineered regulatory T cells (Tregs) to induce tolerance after vascular composite allograft transplants. The research project aims to advance therapeutic...
- This federal Project Grant award of $799,999.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports the "RESUSCITATION BY ENDOTHELIAL STABILIZATION AND TARGETED OXYGEN RESCUE (RESTOR) PLATFORM FOR VASCULARIZED COMPOSITE ALLOTRANSPLANTATION" research project at Wake Forest University Health Sciences (WFUHS), a leading academic medical center and research institution. The goal of this project is to...
- Federal Project Grant Award Summary Wake Forest University Health Sciences received a $2.47 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded September 30, 2025, with a completion date of September 29, 2029. The project, titled "Allograft vs. Autograft to Improve Timely Return to Duty Following Nonunion," supports advanced biomedical research addressing critical health challenges relevant to...
- This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $406,776.00 to Baylor University to develop a novel graft-localized drug delivery platform for reducing innate inflammation and optimizing immunosuppression in vascularized composite allotransplantation. The 2-year project, spanning September 2024 to September 2026, aims to advance innovative biomedical research solutions to improve health outcomes for...
- Federal Project Grant Award Summary Wake Forest University Health Sciences received a $810,171 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, with an ultimate completion date of August 31, 2028. The award supports research investigating the therapeutic effects of peroxisome proliferator-activated receptor alpha agonist on combat-induced proliferative vitreoretinopathy, a condition...
- Federal Grant Award Summary Wake Forest University Health Sciences received a $627,944 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective April 1, 2026, through March 31, 2029. The award supports research focused on modulating immune stress pathways as a strategy for chemotherapy-induced peripheral neuropathy (CIPN) prevention and cancer management. This three-year initiative leverages the institution's...
- Federal Grant Award Summary Wake Forest University Health Sciences received a $770,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on September 15, 2025, with a completion date of September 14, 2028. The award supports the development of advanced biocompatible cryopreservation techniques for eyelid and periorbital tissues, research to be conducted at the institution's facilities in Winston-Salem, North...
- This $1,189,653 Project Grant was awarded by the Defense Health Agency to Wake Forest University Health Sciences on August 1, 2023 under the Military Medical Research and Development program (CFDA 12.420). The purpose of the grant is to develop a stable and effective off-the-shelf wound care treatment for combat burn injuries. Wake Forest University Health Sciences, an academic medical center, will conduct the research and development work over a 3-year period ending on July 31, 2026. As a...
- Federal Grant Award Summary Wake Forest University Health Sciences received a $621,779 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective April 1, 2026 through March 31, 2029. The award supports research titled "Modulating Immune Stress Pathways as a Strategy for CIPN Prevention and Cancer Management," which addresses chemotherapy-induced peripheral neuropathy (CIPN) prevention while advancing cancer...
- Federal Grant Award Summary Wake Forest University Health Sciences received a $1.8M Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective October 1, 2025, through September 30, 2028. The award funds research to develop PEDF (Pigment Epithelium-Derived Factor)-enriched exosomes as a therapeutic intervention to improve urethral sphincter function in patients experiencing post-prostatectomy incontinence (PPI)....